ASURAGEN INC.

In News

Personalized Medicine Market Size, Share, Growth, Analysis, 2034 - Straits Research

Straits Research - Mar 30, 2026

Bio-Techne to Acquire Asuragen - PR Newswire

PR Newswire - Mar 03, 2021

Asuragen Expands Oncology Portfolio - Clinical Lab Products

Clinical Lab Products - Oct 01, 2020

The role of AGG interruptions in fragile X repeat expansions: a twenty-year perspective - Frontiers

Frontiers - Feb 10, 2024

Huntington's Diagnostic Test AmplideX Is Fast, Reliable, Developer Asuragen Says - huntingtonsdiseasenews.com

huntingtonsdiseasenews.com - Jan 15, 2019

Fragile X Added to Newborn Screening in North Carolina Through New Study - Fragile X News Today

Fragile X News Today - Oct 30, 2018

Abnormally Methylated FMR1 in Absence of a Detectable Full Mutation in a U.S.A Patient Cohort Referred for Fragile X Testing - Nature

Nature - Oct 25, 2019

Hyper Personalized Medicine Market Size & Growth Report, 2030 - Allied Market Research

Allied Market Research - Feb 17, 2023

12 Biotech Companies In Texas To Know 2025 - Built In Austin

Built In Austin - Oct 20, 2023

Personalized Medicine Market Size to Reach USD 1,176.66 Billion By 2033 - BioSpace

BioSpace - Sep 16, 2024

Kit Aids in Monitoring TKI Therapy - Clinical Lab Products

Clinical Lab Products - Sep 30, 2020

Meet David Lowe, CEO, Aeglea Biotherapeutics Holdings LLC - The Business Journals

The Business Journals - Apr 03, 2015

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment